FASEB J. Integrated DNA Technologies
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Published as doi: 10.1096/fj.08-118919.
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow Buy
Right arrow All Versions of this Article:
fj.08-118919v1
23/8/2702    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by De, A.
Right arrow Articles by Gambhir, S. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by De, A.
Right arrow Articles by Gambhir, S. S.
(The FASEB Journal. 2009;23:2702-2709.)
© 2009 FASEB

BRET3: a red-shifted bioluminescence resonance energy transfer (BRET)-based integrated platform for imaging protein-protein interactions from single live cells and living animals

Abhijit De*,1, Pritha Ray*,1, Andreas Markus Loening*,{dagger} and Sanjiv Sam Gambhir*,{dagger},2

* Molecular Imaging Program at Stanford and Bio-X Program, Department of Radiology, and

{dagger} Department of Bioengineering, School of Medicine, Stanford University, Stanford, California, USA

2 Correspondence: Stanford University School of Medicine, Department of Radiology, Bioengineering and Bio-X Program, The James H. Clark Center, 318 Campus Dr., E150, Stanford, CA 94305-5427, USA. E-mail: sgambhir{at}stanford.edu

Taking advantage of the bioluminescence resonance energy transfer (BRET) phenomenon, we report the development of a highly photon-efficient, self-illuminating fusion protein combining a mutant red fluorescent protein (mOrange) and a mutant Renilla reniformis luciferase (RLuc8). This new BRET fusion protein (BRET3) exhibits severalfold improvement in light intensity in comparison with existing BRET fusion proteins. BRET3 also exhibits the most red-shifted light output (564-nm peak wavelength) of any reported bioluminescent protein that utilizes its natural substrate coelenterazine, a benefit of which is demonstrated at various tissue depths in small animals. The imaging utility of BRET3 at the single-cell level is demonstrated using an intramolecular sensor incorporating two mammalian target of rapamycin pathway proteins (FKBP12 and FRB) that dimerize only in the presence of rapamycin. With its increased photon intensity, red-shifted light output, and good spectral resolution (~85 nm), BRET3 shows improved spatial and temporal resolution for measuring intracellular events in single cells and in living small animal models. The development of further BRET3-based assays will allow imaging of protein-protein interactions using a single assay directly scalable from intact living cells to small living subjects, allowing accelerated drug discovery.—De, A., Ray, P., Loening, A. M., Gambhir, S. S. BRET3: a red-shifted bioluminescence resonance energy transfer (BRET) based integrated platform for imaging protein-protein interactions from single live cells and living animals.


Key Words: Renilla luciferase • red fluorescent protein • self-illuminating fluorescent protein • cooled charge-coupled device camera







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by The Federation of American Societies for Experimental Biology.